My issue, with BLT, is not what the technology has the potential to deliver, it's somewhat the targets they picked and also, it's a time thing, given it's a brand new technology, the fact such technology was allowed to sit, for years, in limbo by regulators and others, is a scandal IMO.
Again, targeting things like, hypertension and T2D would put this thing into really game changing space! [particularly hypertension - T2D already got some game changers starting to appear ie, MSB in Oz and Xbiotech in the US and others].
Calimmune is fascinating and very welcome in the HIV/AIDS space, but the Hep space? hmmm. But then again, they too can "prove" the technology.
Just an end of the work day rant. Now...back to reality....
- Forums
- ASX - By Stock
- Hep c vaccine from.....Cuba?
My issue, with BLT, is not what the technology has the potential...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online